DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 113 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $7,282,000 | -41.8% | 361,222 | +7.7% | 0.00% | -50.0% |
Q2 2021 | $12,520,000 | +15.5% | 335,486 | -20.9% | 0.01% | 0.0% |
Q1 2021 | $10,839,000 | +33.8% | 423,889 | +15.3% | 0.01% | +33.3% |
Q4 2020 | $8,102,000 | +85.4% | 367,783 | +51.4% | 0.01% | +20.0% |
Q3 2020 | $4,369,000 | -61.0% | 242,864 | -44.9% | 0.01% | -66.7% |
Q2 2020 | $11,198,000 | -1.4% | 440,856 | -28.7% | 0.02% | -42.3% |
Q1 2020 | $11,354,000 | -17.7% | 618,085 | -1.3% | 0.03% | +52.9% |
Q4 2019 | $13,789,000 | +155.6% | 625,910 | +66.6% | 0.02% | +88.9% |
Q3 2019 | $5,394,000 | -55.2% | 375,640 | -50.9% | 0.01% | -50.0% |
Q2 2019 | $12,039,000 | +537.7% | 764,394 | +493.1% | 0.02% | +500.0% |
Q1 2019 | $1,888,000 | +43.1% | 128,877 | +4.4% | 0.00% | +50.0% |
Q4 2018 | $1,319,000 | -17.2% | 123,423 | +18.2% | 0.00% | 0.0% |
Q3 2018 | $1,593,000 | +65.1% | 104,414 | +32.6% | 0.00% | +100.0% |
Q2 2018 | $965,000 | -75.2% | 78,765 | -80.7% | 0.00% | -80.0% |
Q1 2018 | $3,896,000 | +545.0% | 407,530 | +509.1% | 0.01% | +400.0% |
Q4 2017 | $604,000 | +282.3% | 66,907 | +142.8% | 0.00% | – |
Q3 2017 | $158,000 | +39.8% | 27,559 | -29.6% | 0.00% | – |
Q4 2016 | $113,000 | -56.7% | 39,140 | -11.7% | 0.00% | – |
Q3 2016 | $261,000 | +65.2% | 44,322 | -15.9% | 0.00% | – |
Q2 2016 | $158,000 | +46.3% | 52,693 | +162.6% | 0.00% | – |
Q1 2016 | $108,000 | -96.9% | 20,064 | -93.1% | 0.00% | -100.0% |
Q4 2015 | $3,473,000 | +21.9% | 292,560 | -15.7% | 0.01% | +16.7% |
Q3 2015 | $2,849,000 | -47.7% | 347,044 | -11.1% | 0.01% | -40.0% |
Q2 2015 | $5,447,000 | – | 390,464 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |